Key Takeaway: Dr. Sreeraj Pillai is a seasoned cancer biologist with over 16 years of experience in both basic and translational research. His focus has been on Disseminated Tumor Cells (DTCs) in breast cancer, exploring their impact on disease progression and metastasis. He holds a Ph.D. from India and has conducted postdoctoral research at prestigious institutions in St. Louis.
Price reaction · baseline $6.73 (2025-12-26 close) · 22 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
-1%
Market Sentiment Analysis
POSITIVE FACTORS
Dr. Pillai has over 16 years of experience in cancer research.
He has made significant contributions to understanding DTCs in breast cancer.
His work on cell death regulation mechanisms is noteworthy.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+41%
120-day peak, hindsight
Typical move
11.4%
average across 8 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 Monotherapy
Phase 1 · Advanced Solid Tumor
Full Press Release Details
Dr. Pillai is a Cancer biologist with more than 16 years of experience in basic and translational cancer research. He devoted over a decade into investigating the molecular features of Disseminated Tumor Cells (DTCs) from the bone marrow of breast cancer patients, and studying their role in disease progression and metastasis at the Department of Surgery, Washington University School of Medicine in St Louis. Dr. Pillai has also studied and published on the mechanisms of cell death regulation in tumor cells and its role in tumor progression. Dr. Pillai earned a Ph.D. from Indian Council for Agricultural Research (Central Institute of Fisheries Education), India and completed post doctoral research at Saint Louis University and Washington University in St Louis.
Frequently Asked Questions
What is Dr. Sreeraj Pillai's area of expertise?
Dr. Pillai specializes in cancer biology, focusing on disseminated tumor cells.
How long has Dr. Pillai been in cancer research?
He has over 16 years of experience in basic and translational cancer research.
Where did Dr. Pillai complete his Ph.D.?
He earned his Ph.D. from the Indian Council for Agricultural Research in India.
What significant research has Dr. Pillai conducted?
He has investigated the role of DTCs in breast cancer progression and metastasis.